现代肿瘤医学
現代腫瘤醫學
현대종류의학
Journal of Modern Oncology
2015年
23期
3414-3417
,共4页
权芳%李白芽%姚小宝%邵渊
權芳%李白芽%姚小寶%邵淵
권방%리백아%요소보%소연
浆母细胞性淋巴瘤%HIV 阴性%鼻腔肿瘤
漿母細胞性淋巴瘤%HIV 陰性%鼻腔腫瘤
장모세포성림파류%HIV 음성%비강종류
plasmablastic lymphoma%HIV negative%carcinoma of nose
目的:探讨浆母细胞性淋巴瘤(PBL)的病因、诊断、治疗及预后。方法:对2014年收治的1例鼻腔HIV 阴性 PBL 患者的临床资料进行回顾性分析,并复习国内外相关文献。结果:1例患者诊断明确,HIV 阴性。以间断右侧鼻出血发病,后发现鼻腔有肿瘤生长,骨质破坏向右侧额窦、筛窦、上颌窦浸润并伴有双侧淋巴结转移。行鼻侧切开肿瘤切除术+双侧颈淋巴结清扫术,术后病理表现弥漫性大细胞淋巴瘤的形态学特征,同时表现出典型的浆细胞表型。免疫组化示 CD38、CD138、MUM -1阳性,CyD1部分阳性,Ki -67阳性90%。EBER 原位杂交部分阳性。LCA、CD79a、CD20、CD30、ALK、Bcl -2、Bcl -6、CD10、CD3、CK、EMA、PAX-5阴性,符合浆母细胞性淋巴瘤。术后给予化学药物治疗,现肿瘤复发正在随访中。结论:PBL 罕见,恶性程度高,预后极差。患者对化疗药物的敏感性低,生存期短。
目的:探討漿母細胞性淋巴瘤(PBL)的病因、診斷、治療及預後。方法:對2014年收治的1例鼻腔HIV 陰性 PBL 患者的臨床資料進行迴顧性分析,併複習國內外相關文獻。結果:1例患者診斷明確,HIV 陰性。以間斷右側鼻齣血髮病,後髮現鼻腔有腫瘤生長,骨質破壞嚮右側額竇、篩竇、上頜竇浸潤併伴有雙側淋巴結轉移。行鼻側切開腫瘤切除術+雙側頸淋巴結清掃術,術後病理錶現瀰漫性大細胞淋巴瘤的形態學特徵,同時錶現齣典型的漿細胞錶型。免疫組化示 CD38、CD138、MUM -1暘性,CyD1部分暘性,Ki -67暘性90%。EBER 原位雜交部分暘性。LCA、CD79a、CD20、CD30、ALK、Bcl -2、Bcl -6、CD10、CD3、CK、EMA、PAX-5陰性,符閤漿母細胞性淋巴瘤。術後給予化學藥物治療,現腫瘤複髮正在隨訪中。結論:PBL 罕見,噁性程度高,預後極差。患者對化療藥物的敏感性低,生存期短。
목적:탐토장모세포성림파류(PBL)적병인、진단、치료급예후。방법:대2014년수치적1례비강HIV 음성 PBL 환자적림상자료진행회고성분석,병복습국내외상관문헌。결과:1례환자진단명학,HIV 음성。이간단우측비출혈발병,후발현비강유종류생장,골질파배향우측액두、사두、상합두침윤병반유쌍측림파결전이。행비측절개종류절제술+쌍측경림파결청소술,술후병리표현미만성대세포림파류적형태학특정,동시표현출전형적장세포표형。면역조화시 CD38、CD138、MUM -1양성,CyD1부분양성,Ki -67양성90%。EBER 원위잡교부분양성。LCA、CD79a、CD20、CD30、ALK、Bcl -2、Bcl -6、CD10、CD3、CK、EMA、PAX-5음성,부합장모세포성림파류。술후급여화학약물치료,현종류복발정재수방중。결론:PBL 한견,악성정도고,예후겁차。환자대화료약물적민감성저,생존기단。
Objective:To investigate the origin,diagnosis,differential diagnosis,treatment,and prognosis of plas-mablastic lymphoma(PBL). Methods:To retrospectively analyze the clinical data of one patient with PBL. Results:The patient was a 55 - year - old man. He was explicitly diagnosed to be HIV negative. He presented enlarged tumor in the right nose with lymph node metastasis. The tumor displayed the morphology characteristics of diffused large cell lymphoma and the typical plasma cell phenotype. Immunohistochemical analysis revealed that the cells stained posi-tively for CD38,CD138,MUM - 1,CyD1. Nuclear proliferation rate as assessed by Ki - 67 staining was approximately 90% . And the cells stained poorly or even negatively for LCA,CD79a,CD20,CD30,ALK,Bcl - 2,Bcl - 6,CD10, CD3,CK,EMA,PAX - 5. Histochemistry in situ hybridization of EBER was positive. CHOP regime showed no satis-factory effect. Relapse appeared quickly after a brief remission. Conclusion:PBL is very rare,with malignancy and poor prognosis. All PBL patients present low sensitivity to chemotherapy drugs and exhibit short survival rate. There is no standard chemotherapy regimen for PBL.